March 04, 2015 7:17 AM ET


Company Overview of Proteostasis Therapeutics, Inc.

Executive Profile

F. Ulrich Hartl M.D., D. Med

AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships


F. Ulrich Hartl, M.D. D. Med serves as Scientific Advisor and SAB Chairman of ProteoStasis Therapeutics, Inc. Dr. Hartl is a co-founder of Mojave Therapeutics, Inc. He has affiliation with Max-Planck-Institut for Biochemistry, Munich, Germany. He has expertise knowledge in Chaperone protein chemistry field. He serves as Professor and Director of Department of Cellular Biochemistry at Max Planck Institute of Biochemistry. He served as Head of the Department of Cellular ...

Corporate Headquarters

200 Technology Square
Cambridge, Massachusetts 02139

United States

Phone: 617-225-0096
Fax: 617-632-5739

Board Members Memberships

There is no Board Members Memberships data available.


University of Heidelberg

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Proteostasis Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at